US Stock MarketDetailed Quotes

DTIL Precision BioSciences

Watchlist
  • 5.4400
  • -0.6800-11.11%
Close Dec 13 16:00 ET
  • 5.4400
  • 0.00000.00%
Post 20:02 ET
41.73MMarket Cap-19.43P/E (TTM)

Precision BioSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
74.40%-5.91M
29.64%-14.87M
39.67%-18.98M
-83.84%-84.11M
61.44%-8.42M
-179.12%-23.09M
12.76%-21.13M
-8.98%-31.46M
-321.57%-45.75M
7.76%-21.84M
Net income from continuing operations
-103.30%-16.43M
375.41%32.75M
134.27%8.59M
45.07%-61.32M
42.82%-16.29M
66.26%-8.08M
61.69%-11.89M
11.03%-25.06M
-264.80%-111.64M
-27.81%-28.49M
Operating gains losses
60.92%-2.77M
-1,420.83%-6.97M
-652.01%-11.69M
-275.19%-2.95M
158.57%1.5M
-497.87%-7.09M
-64.68%528K
119.83%2.12M
127.43%1.69M
58.55%-2.56M
Depreciation and amortization
-50.34%1.01M
-42.05%1.38M
-37.36%1.43M
-8.32%8.26M
-31.60%1.56M
-9.39%2.04M
7.14%2.39M
0.98%2.28M
-11.70%9M
-8.78%2.28M
Other non cash items
-403.11%-1.17M
-206.67%-138K
-5.04%113K
-387.11%-1.29M
-447.62%-1.75M
9,750.00%386K
-325.00%-45K
270.00%119K
102.21%450K
119.76%504K
Change In working capital
178.08%9.9M
-165.43%-44.47M
-35.44%-20.33M
-272.07%-41.49M
130.94%2.96M
-128.83%-12.68M
-710.15%-16.75M
-82.09%-15.01M
23.11%24.11M
-7,865.85%-9.55M
-Change in receivables
443.86%9.77M
335.71%183K
-3,361.54%-848K
21.98%-181K
51,940.00%2.59M
-105.71%-2.84M
100.08%42K
--26K
-102.44%-232K
---5K
-Change in prepaid assets
-557.59%-1.45M
830.35%3.59M
-275.80%-3.28M
209.25%1.05M
134.37%2.1M
-7.06%316K
-111.09%-491K
-333.16%-872K
-117.13%-962K
-202.78%-6.1M
-Change in payables and accrued expense
-264.71%-186K
4.35%120K
-276.03%-2.1M
885.62%1.51M
489.12%2M
-113.14%-51K
157.21%115K
-49.47%-559K
-82.35%153K
-45.77%340K
-Change in other current assets
-108.72%-51K
-102.56%-39K
90.02%-57K
22.43%1.75M
-96.52%213K
550.00%585K
130.81%1.53M
-433.92%-571K
152.34%1.43M
320.06%6.12M
-Change in other current liabilities
367.25%1.22M
37.90%2.09M
-21.95%-6.1M
54.10%-1.67M
262.38%2.28M
-195.99%-455K
-47.37%1.51M
10.42%-5M
-609.16%-3.64M
-402.59%-1.4M
-Change in other working capital
105.83%597K
-159.06%-50.41M
1.08%-7.95M
-260.64%-43.95M
26.77%-6.23M
-43.89%-10.23M
-142.48%-19.46M
-183.82%-8.03M
300.20%27.36M
-106.11%-8.5M
Cash from discontinued investing activities
Operating cash flow
74.40%-5.91M
29.64%-14.87M
39.67%-18.98M
-83.84%-84.11M
61.44%-8.42M
-179.12%-23.09M
12.76%-21.13M
-8.98%-31.46M
-321.57%-45.75M
7.76%-21.84M
Investing cash flow
Cash flow from continuing investing activities
-100.85%-64K
97.35%-28K
96.39%-26K
275.63%5.83M
106.65%42K
793.94%7.56M
-35.56%-1.06M
11.86%-721K
42.81%-3.32M
58.01%-632K
Net PPE purchase and sale
89.90%-39K
97.22%-28K
95.01%-26K
44.26%-1.85M
109.97%63K
64.59%-386K
-29.14%-1.01M
36.31%-521K
34.32%-3.32M
58.01%-632K
Net intangibles purchase and sale
50.00%-25K
--0
--0
---321K
---21K
---50K
---50K
---200K
--0
--0
Net business purchase and sale
----
----
----
--8M
--0
----
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
-100.85%-64K
97.35%-28K
96.39%-26K
275.63%5.83M
106.65%42K
793.94%7.56M
-35.56%-1.06M
11.86%-721K
42.81%-3.32M
58.01%-632K
Financing cash flow
Cash flow from continuing financing activities
11,079.41%3.73M
-62.10%702K
5,310.93%40.1M
-94.33%5.39M
2.83M
81.11%-34K
-98.01%1.85M
-67.05%741K
34.69%94.99M
0
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
701.82%19.81M
-200.00%-5K
Net common stock issuance
2,718.12%3.61M
-62.10%702K
8,884.94%39.98M
-93.29%4.99M
--2.83M
27.37%-138K
-97.46%1.85M
-72.65%445K
22.93%74.35M
--0
Proceeds from stock option exercised by employees
31.73%137K
--0
-62.16%112K
-51.98%401K
-80.00%1K
-38.82%104K
--0
-52.41%296K
-88.99%835K
-99.51%5K
Cash from discontinued financing activities
Financing cash flow
11,079.41%3.73M
-62.10%702K
5,310.93%40.1M
-94.33%5.39M
--2.83M
81.11%-34K
-98.01%1.85M
-67.05%741K
34.69%94.99M
--0
Net cash flow
Beginning cash position
-10.32%123.57M
-12.88%137.77M
-38.45%116.68M
31.96%189.58M
-42.36%122.23M
-25.17%137.79M
36.06%158.13M
31.96%189.58M
59.98%143.66M
32.14%212.05M
Current changes in cash
85.59%-2.24M
30.20%-14.2M
167.07%21.09M
-258.77%-72.9M
75.29%-5.55M
-155.75%-15.56M
-129.95%-20.34M
-14.59%-31.44M
-14.76%45.91M
-33.72%-22.48M
End cash Position
-0.74%121.33M
-10.32%123.57M
-12.88%137.77M
-38.45%116.68M
-38.45%116.68M
-42.36%122.23M
-25.17%137.79M
36.06%158.13M
31.96%189.58M
31.96%189.58M
Free cash flow
74.60%-5.98M
33.08%-14.9M
40.76%-19.07M
-76.05%-86.39M
62.55%-8.42M
-183.75%-23.53M
10.97%-22.26M
-8.40%-32.19M
-194.62%-49.07M
10.76%-22.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 74.40%-5.91M29.64%-14.87M39.67%-18.98M-83.84%-84.11M61.44%-8.42M-179.12%-23.09M12.76%-21.13M-8.98%-31.46M-321.57%-45.75M7.76%-21.84M
Net income from continuing operations -103.30%-16.43M375.41%32.75M134.27%8.59M45.07%-61.32M42.82%-16.29M66.26%-8.08M61.69%-11.89M11.03%-25.06M-264.80%-111.64M-27.81%-28.49M
Operating gains losses 60.92%-2.77M-1,420.83%-6.97M-652.01%-11.69M-275.19%-2.95M158.57%1.5M-497.87%-7.09M-64.68%528K119.83%2.12M127.43%1.69M58.55%-2.56M
Depreciation and amortization -50.34%1.01M-42.05%1.38M-37.36%1.43M-8.32%8.26M-31.60%1.56M-9.39%2.04M7.14%2.39M0.98%2.28M-11.70%9M-8.78%2.28M
Other non cash items -403.11%-1.17M-206.67%-138K-5.04%113K-387.11%-1.29M-447.62%-1.75M9,750.00%386K-325.00%-45K270.00%119K102.21%450K119.76%504K
Change In working capital 178.08%9.9M-165.43%-44.47M-35.44%-20.33M-272.07%-41.49M130.94%2.96M-128.83%-12.68M-710.15%-16.75M-82.09%-15.01M23.11%24.11M-7,865.85%-9.55M
-Change in receivables 443.86%9.77M335.71%183K-3,361.54%-848K21.98%-181K51,940.00%2.59M-105.71%-2.84M100.08%42K--26K-102.44%-232K---5K
-Change in prepaid assets -557.59%-1.45M830.35%3.59M-275.80%-3.28M209.25%1.05M134.37%2.1M-7.06%316K-111.09%-491K-333.16%-872K-117.13%-962K-202.78%-6.1M
-Change in payables and accrued expense -264.71%-186K4.35%120K-276.03%-2.1M885.62%1.51M489.12%2M-113.14%-51K157.21%115K-49.47%-559K-82.35%153K-45.77%340K
-Change in other current assets -108.72%-51K-102.56%-39K90.02%-57K22.43%1.75M-96.52%213K550.00%585K130.81%1.53M-433.92%-571K152.34%1.43M320.06%6.12M
-Change in other current liabilities 367.25%1.22M37.90%2.09M-21.95%-6.1M54.10%-1.67M262.38%2.28M-195.99%-455K-47.37%1.51M10.42%-5M-609.16%-3.64M-402.59%-1.4M
-Change in other working capital 105.83%597K-159.06%-50.41M1.08%-7.95M-260.64%-43.95M26.77%-6.23M-43.89%-10.23M-142.48%-19.46M-183.82%-8.03M300.20%27.36M-106.11%-8.5M
Cash from discontinued investing activities
Operating cash flow 74.40%-5.91M29.64%-14.87M39.67%-18.98M-83.84%-84.11M61.44%-8.42M-179.12%-23.09M12.76%-21.13M-8.98%-31.46M-321.57%-45.75M7.76%-21.84M
Investing cash flow
Cash flow from continuing investing activities -100.85%-64K97.35%-28K96.39%-26K275.63%5.83M106.65%42K793.94%7.56M-35.56%-1.06M11.86%-721K42.81%-3.32M58.01%-632K
Net PPE purchase and sale 89.90%-39K97.22%-28K95.01%-26K44.26%-1.85M109.97%63K64.59%-386K-29.14%-1.01M36.31%-521K34.32%-3.32M58.01%-632K
Net intangibles purchase and sale 50.00%-25K--0--0---321K---21K---50K---50K---200K--0--0
Net business purchase and sale --------------8M--0--------------0--0
Cash from discontinued investing activities
Investing cash flow -100.85%-64K97.35%-28K96.39%-26K275.63%5.83M106.65%42K793.94%7.56M-35.56%-1.06M11.86%-721K42.81%-3.32M58.01%-632K
Financing cash flow
Cash flow from continuing financing activities 11,079.41%3.73M-62.10%702K5,310.93%40.1M-94.33%5.39M2.83M81.11%-34K-98.01%1.85M-67.05%741K34.69%94.99M0
Net issuance payments of debt --------------0--0------------701.82%19.81M-200.00%-5K
Net common stock issuance 2,718.12%3.61M-62.10%702K8,884.94%39.98M-93.29%4.99M--2.83M27.37%-138K-97.46%1.85M-72.65%445K22.93%74.35M--0
Proceeds from stock option exercised by employees 31.73%137K--0-62.16%112K-51.98%401K-80.00%1K-38.82%104K--0-52.41%296K-88.99%835K-99.51%5K
Cash from discontinued financing activities
Financing cash flow 11,079.41%3.73M-62.10%702K5,310.93%40.1M-94.33%5.39M--2.83M81.11%-34K-98.01%1.85M-67.05%741K34.69%94.99M--0
Net cash flow
Beginning cash position -10.32%123.57M-12.88%137.77M-38.45%116.68M31.96%189.58M-42.36%122.23M-25.17%137.79M36.06%158.13M31.96%189.58M59.98%143.66M32.14%212.05M
Current changes in cash 85.59%-2.24M30.20%-14.2M167.07%21.09M-258.77%-72.9M75.29%-5.55M-155.75%-15.56M-129.95%-20.34M-14.59%-31.44M-14.76%45.91M-33.72%-22.48M
End cash Position -0.74%121.33M-10.32%123.57M-12.88%137.77M-38.45%116.68M-38.45%116.68M-42.36%122.23M-25.17%137.79M36.06%158.13M31.96%189.58M31.96%189.58M
Free cash flow 74.60%-5.98M33.08%-14.9M40.76%-19.07M-76.05%-86.39M62.55%-8.42M-183.75%-23.53M10.97%-22.26M-8.40%-32.19M-194.62%-49.07M10.76%-22.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.